StonvexLoading…
StonvexStonvexStonvexCore line items from CLNV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $125.20K | $63.14K | $10.53K | $231.04K |
Operating Income | $-4.17M | $-2.96M | $-1.03M | $-7.31M |
Net Income | $-5.48M | $-3.65M | $-3.23M | $-14.00M |
EPS (Diluted) | $-0.01 | $0.00 | $0.00 | $-0.02 |
Total Assets | $20.85M | $21.69M | $17.70M | $13.07M |
Total Liabilities | $36.32M | $36.02M | $32.59M | $24.97M |
Cash & Equivalents | $1.98M | $3.51M | $1.80M | $1.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.09B | 1.04B | 898.02M | 807.61M |